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ABSTRACT	  
Individually, tuberculosis (TB) and acquired immunodeficiency syndrome (AIDS) pose major global health 
problems and together, they form a deadly liaison. Preventive vaccines for any of the diseases are not yet 
available. Therefore, better understanding of protective immunity to each pathogen that cause the diseases and 
how co-infection influences host immune responses are urgently needed. The overall aim of this thesis was to 
increase our understanding of immune regulation and protective immune responses during pulmonary TB and 
during Mycobacterium tuberculosis (Mtb)/ human immunodeficiency virus-1 (HIV-1) co-infection in the mouse 
model. 
In study I, we explored CD103+ dendritic cell (αE-DC) and CD4+Foxp3+ regulatory T (Treg) cell function 
during pulmonary TB.  We showed that in mice resistant to Mtb infection the number of αE-DCs increased 
dramatically in response to Mtb infection. In contrast, highly susceptible mice failed to recruit αE-DCs even 
during chronic infection. Instead of producing TNFα, αE-DCs preferentially produced TGFβ.  In contrast to 
resistant mice, the Treg cell population was diminished in the lungs, but not in the draining pulmonary lymph 
node (PLN) of highly susceptible DBA/2 mice during chronic infection. Further, we showed that Treg cells 
produced IFNγ in response to infection with a virulent clinical Mtb isolate. The reduced number of lung αE-DCs 
and Treg cells in susceptible mice coincided with severe lung inflammation and increased bacterial burden. Our 
results indicated that αE-DCs and Treg cells may play a role in regulating the host immune response during 
pulmonary TB.  
In study II, we further investigated the origin, tissue localization, infection rate and cytokine profile of αE-DCs 
during pulmonary TB. We showed that alveolar epithelial cells support monocyte survival and differentiation in 
vitro. We demonstrated that bone marrow-derived monocytes were precursors of αE-DCs in the lungs and PLN 
during pulmonary TB.  We confirmed the localization of αE-DCs beneath the bronchial epithelial cell layer and 
near the vascular wall during steady state conditions, and showed that αE-DCs had a similar localizaton in the 
lungs during pulmonary TB. In addition, αE-DCs were detected in the bronchoalveolar lavage during the 
infection.  In contrast to other DC subsets, we found that only a minor fraction of lung αE-DCs was infected with 
the bacterium. We also showed that virulent Mtb did not significantly alter the cell surface expression level of 
MHC II on infected cells in vivo and that αE-DCs contain the highest frequency of IL-12p40+ cells among the 
myeloid cell subsets in infected lungs. Our results support a model in which inflammatory monocytes are 
recruited into the Mtb-infected lung tissue and, depending on which non-hematopoietic cells they interact with, 
differentiate along different paths to give rise to multiple monocyte-derived cells, including DC with a distinctive 
αE-DCs phenotype. 
In study III, we determined the impact of chronic Mtb infection on the immunogenicity of a HIV vaccine 
candidate.  We found that, depending on the vaccination route, Mtb-infected mice displayed impairment in both 
the magnitude and in the quality of both antibody- and T cell responses to the vaccine components p24Gag and 
gp160Env. Mtb-infected and HIV-vaccinated mice exhibited reduced p24Gag-specific serum IgG and IgA titers, 
and suppressed gp160Env-specific serum IgG titers compared to uninfected HIV-1-vaccinated controls. 
Importantly, the virus neutralizing activity in serum of intramuscular HIV-vaccinated Mtb-infected mice was 
significantly decreased relative to the uninfected controls.  In addition mice concurrently infected with Mtb had 
fewer p24Gag-specific IFNγ-expressing T cells and multifunctional T cells in the spleen.  These results 
suggested that Mtb infection may interfere with the effectiveness of HIV vaccines in humans.  
In study IV, we established a mouse model for Mtb/HIV-1 co-infection by utilizing the chimeric EcoNDK virus. 
During the time-course of the experiment, we did not detect signs of immunodeficiency.  However, we 
confirmed that the virus was present in Mtb/EcoNDK co-infected mice at least 14 days after a single injection of 
the virus.  In fact, the viral load was significantly higher in the lungs and in the spleen of Mtb/EcoNDK co-
infected mice compared to animals infected with the virus alone. We showed that EcoNDK influence the 
adaptive T cell response directed towards the bacterium. We observed that the number of Mtb-specific CD8+ T 
cells was significantly increased in the spleen compared to Mtb-infected animals. Furthermore, we characterized 
the cell surface expression profile of T cell immunoglobulin and mucin domain-3 (Tim-3) and Program Death 1 
(PD-1) on T cell subsets during TB and during Mtb/EcoNDK co-infection. Even though we did not detect any 
significant difference between Mtb-infected and co-infected mice, we did find that Tim-3 and PD-1 were utilized 
differently by CD4+ T cells and CD8+ T cell subsets.  Finally, we showed that TB10.4-specific CD8+Tim-3+ T 
cells were enriched for both TNFα- and IFNγ-producing cells.  Our murine co-infection model may be a useful 
tool to elucidate why pulmonary TB is such a problem in patients with HIV-1/AIDS. 
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